Science Explorer Back to mapMap
Discussion
Researcher · Aichi Developmental Disability Center · Japan

Shigeo Masaki

Shigeo Masaki publishes mostly in Molecular Biology, Genetics and Immunology, on topics such as Connexins and lens biology, Monoclonal and Polyclonal Antibodies Research and Animal Genetics and Reproduction.

OpenAlex
World rank
#4,510,866
of 7,710,434 ranked researchers
Rank in Japan
#131,299
of 383,136
Works
44
Citations
981
Citations per work
22.3
h-index
16
i10-index 24Top 46% in Molecular Biology
Shigeo Masaki

What does Shigeo Masaki research?

Shigeo Masaki's work is mostly in Biochemistry, Genetics and Molecular Biology (60%), Medicine (7%), Immunology and Microbiology (5%).

Life Sciences: 28 works · 64.3% of their workBiochemistry, Genetics and Molecular Biology: 26 works · 59.5% of their workMolecular Biology: 21 works · 46.8% of their workGenetics: 4 works · 8.7% of their workCell Biology: 2 works · 4.0% of their workImmunology and Microbiology: 2 works · 4.8% of their workImmunology: 2 works · 4.8% of their workEverything else: 13 works · 28.5% of their workHealth Sciences: 3 works · 7.2% of their workMedicine: 3 works · 7.2% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 4.0% of their workCardiology and Cardiovascular Medicine: 1 works · 3.2% of their workTHEIR WORKShigeo Masaki44works
Life Sciences64%Health Sciences7%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2659.5%
    2. Immunology and Microbiology24.8%
  2. Everything else1328.5%
    1. Medicine37.2%
  1. 1Molecular Biology47% of their works
  2. 2Genetics9% of their works
  3. 3Immunology5% of their works
  4. 4Cell Biology4% of their works
  5. 5Radiology, Nuclear Medicine and Imaging4% of their works
  6. 6Cardiology and Cardiovascular Medicine3% of their works

Research topics

Which keywords describe Shigeo Masaki's research?

The keywords of their largest research topics: Connexins, Gap Junctions, Fc Receptors, Therapeutic Antibodies, DNA Structure, G-Quadruplexes, Genetic Modification and Genome Engineering.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Connexins101 topic
  2. Gap Junctions101 topic
  3. Fc Receptors51 topic
  4. Therapeutic Antibodies51 topic
  5. DNA Structure41 topic
  6. G-Quadruplexes41 topic
  7. Genetic Modification41 topic
  8. Genome Engineering41 topic
  9. RNA-Guided41 topic
  10. Transgenic Animals41 topic
  11. Genetic Heterogeneity31 topic
  12. Limb Malformations31 topic
  13. Nuclear Pore Complex31 topic
  14. Nucleocytoplasmic Transport31 topic
  15. RNA Interference31 topic
  16. siRNA Delivery31 topic

Where does Shigeo Masaki work?

Shigeo Masaki's main affiliation in the publication record is Aichi Developmental Disability Center, Japan.

How many publications and citations does Shigeo Masaki have?

OpenAlex counts 44 works and 981 citations for Shigeo Masaki, an h-index of 16, ranking #4,510,866 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Shigeo Masaki. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.